Apolipoprotein A-I mimetic peptide reverse D-4F improves the biological functions of mouse bone marrow-derived late EPCs via PI3K/AKT/eNOS pathway

Molecular and Cellular Biochemistry

Volumn 377, Issue 1-2, 2013, Pages 229-236

  Yang, Nana ^a   Yao, Shutong ^a   Wang, Mengzan ^a   Jiao, Peng ^a   Zhang, Ying ^a   Qin, Shucun ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein A I mimetic peptide; Endothelial progenitor cells; eNOS

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; APOLIPOPROTEIN A1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REVERSE D 4F MIMETIC PEPTIDE; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOMIMETICS; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHROMONES; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION; MICE; MICE, INBRED C57BL; MOLECULAR MIMICRY; MORPHOLINES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STEM CELLS;

MUS;

EID: 84875663843     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1592-z     Document Type: Article

References (28)

1. Morgantini C, Imaizumi S, Grijalva V, Navab M, Fogelman AM, Reddy ST (2010) Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes. Diabetes 59(12):3223-3228
2. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D, Fogelman AM (2004) Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation 109(25):3215-3220
3. Van Lenten BJ, Wagner AC, Jung CL, Ruchala P, Waring AJ, Lehrer RI, Watson AD, Hama S, Navab M, Anantharamaiah GM, Fogelman AM (2008) Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J Lipid Res 49(11):2302-2311
4. Peterson SJ, Husney D, Kruger AL, Olszanecki R, Ricci F, Rodella LF, Stacchiotti A, Rezzani R, McClung JA, Aronow WS, Ikehara S, Abraham NG (2007) Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther 322(2):514-520
5. Zhang Z, Qun J, Cao C, Wang J, Li W, Wu Y, Du L, Zhao P, Gong K (2011) Apolipoprotein A-I mimetic peptide D-4F promotes human endothelial progenitor cell proliferation, migration, adhesion though eNOS/NO pathway. Mol Biol Rep 39(4):4445-4454
6. Qin S, Kamanna VS, Lai JH, Liu T, Ganji SH, Zhang L, Bachovchin WW, Kashyap ML (2012) Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice. J Cardiovasc Pharmacol Ther 17(3):334-343
7. Chiang CH, Huang PH, Chung FP, Chen ZY, Leu HB, Huang CC, Wu TC, Chen JW, Lin SJ (2012) Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoS ONE 7(2):e31799
8. Cacciatore F, Bruzzese G, Vitale DF, Liguori A, de Nigris F, Fiorito C, Infante T, Donatelli F, Minucci PB, Ignarro LJ, Napoli C (2011) Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients. Eur J Clin Pharmacol 67(9):877-883
9. Callaghan MJ, Ceradini DJ, Gurtner GC (2005) Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid Redox Signal 7(11-12):1476-1482
10. Di Stefano R, Barsotti MC, Felice F, Magera A, Lekakis J, Leone A, Balbarini A (2010) Smoking and endothelial progenitor cells: a revision of literature. Curr Pharm Des 16(23):2559-2566
11. Yang L, Guan H, He J, Zeng L, Yuan Z, Xu M, Zhang W, Wu X, Guan J (2012) VEGF increases the proliferative capacity and eNOS/NO levels of endothelial progenitor cells through the calcineurin/NFAT signalling pathway. Cell Biol Int 36(1):21-27
12. Shen L, Gao Y, Qian J, Wu Y, Zhou M, Sun A, Zou Y, Ge J (2012) The role of SDF-1α/Rac pathway in the regulation of endothelial progenitor cell polarity; homing and expression of Rac1, Rac2 during endothelial repair. Mol Cell Biochem 365(1-2):1-7
13. Smadja DM, Laurendeau I, Avignon C, Vidaud M, Aiach M, Gaussem P (2006) The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost 4(9):2051-2058
14. Ioka T, Tsuruoka S, Ito C, Iwaguro H, Asahara T, Fujimura A, Kusano E (2009) Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients. Clin Pharmacol Ther 86(2):154-159
15. Lavi R, Zhu XY, Chade AR, Lin J, Lerman A, Lerman LO (2010) Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 30(5):976-983
16. Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD, Poole-Wilson PA, Borlak J, Ertl G, Bauersachs J (2007) Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 100(3):434-443
17. Zhu G, Song M, Wang H, Zhao G, Yu Z, Yin Y, Zhao X, Huang L (2009) Young environment reverses the declined activity of aged rat-derived endothelial progenitor cells: involvement of the phosphatidylinositol 3-kinase/Akt signaling pathway. Ann Vasc Surg 23(4):519-534
18. Yin T, Ma X, Zhao L, Cheng K, Wang H (2008) Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells. Cell Res 18:792-799
19. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964-967
20. Schatteman GC (2004) Adult bone marrow-derived hemangioblasts, endothelial cell progenitors, and EPCs. Curr Top Dev Biol 64:141-180
21. Fadini GP, Losordo D, Dimmeler S (2012) Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110(4):624-637
22. Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, Lin SJ (2007) Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 93(9):1064-1070
23. Pu DR, Liu L (2008) HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL. Med Hypotheses 70(2):338-342
24. Tso C, Martinic G, Fan WH, Rogers C, Rye KA, Barter PJ (2006) High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol 26(5):1144-1149
25. Predmore BL, Julian D, Cardounel AJ (2011) Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism. Front Physiol 2:104
26. Choi HE, Yoo MS, Choi JH, Lee JY, Kim JH, Kim JH, Lee JK, Kim GI, Park Y, Chi YH, Paik SH, Lee JH, Lee KT (2011) BRN-103, a novel nicotinamide derivative, inhibits VEGF-induced angiogenesis and proliferation in human umbilical vein endothelial cells. Bioorg Med Chem Lett 21(21):6236-6241
27. Presta I, Tassone EJ, Andreozzi F, Perticone M, Sciacqua A, Laino I, Musca D, Martino F, Sesti G, Perticone F (2011) Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs. Atherosclerosis 219(2):463-467
28. Florian M, Lu Y, Angle M, Magder S (2004) Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids 69(10):637-645